Literature DB >> 21266016

A D-peptide analog of the second extracellular loop of claudin-3 and -4 leads to mislocalized claudin and cellular apoptosis in mammary epithelial cells.

Heidi K Baumgartner1, Neal Beeman, Robert S Hodges, Margaret C Neville.   

Abstract

Claudins are cell adhesion proteins thought to mediate cell-cell contacts at the tight junction. Although a major role of claudins is to control paracellular diffusion, increasing evidence suggests that they may also function in tumor progression. To examine the role of the second extracellular loop in cell adhesion, a small peptide was designed, which mimics a conserved sequence, DFYNP, within specific 'classic' claudin subtypes. Using fluorescent indicators with mammary epithelial cells, treatment with both the L- and D-forms of this peptide showed mislocalization of claudin-4 and claudin-3 and activation of caspase-8 and caspase-3, indicating apoptosis. To test specificity, peptides were made both with various end-groups and with glycine substitutions at each of the five residues. Changing end-groups did not influence the activity of the peptide. Amino acid substitutions at F147, Y148, N149, or P150, however, prevented peptide activity. A fluorescent-labeled peptide was shown to associate with the tight junction at 4 °C and cause apoptosis when the cultures were warmed to 37 °C. In conclusion, both the D- and L-forms of a small peptide that mimics a sequence in the second extracellular loop of claudins can target and disrupt claudin proteins in an epithelial monolayer and initiate apoptosis.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266016      PMCID: PMC3080100          DOI: 10.1111/j.1747-0285.2010.01061.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  44 in total

Review 1.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

2.  Structure and function of extracellular claudin domains.

Authors:  Gerd Krause; Lars Winkler; Christian Piehl; Ingolf Blasig; Jörg Piontek; Sebastian L Müller
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

3.  Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Martha L Hale; Michel R Popoff; Bradley G Stiles; Bruce A McClane
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

4.  Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family.

Authors:  Emily Steed; Nelio T L Rodrigues; Maria S Balda; Karl Matter
Journal:  BMC Cell Biol       Date:  2009-12-22       Impact factor: 4.241

5.  Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.

Authors:  Shufeng Liu; Wei Yang; Le Shen; Jerrold R Turner; Carolyn B Coyne; Tianyi Wang
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

6.  Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions.

Authors:  David R Raleigh; Amanda M Marchiando; Yong Zhang; Le Shen; Hiroyuki Sasaki; Yingmin Wang; Manyuan Long; Jerrold R Turner
Journal:  Mol Biol Cell       Date:  2010-02-17       Impact factor: 4.138

7.  Claudin-7 expression in human epithelial ovarian cancer.

Authors:  R A Tassi; E Bignotti; M Falchetti; M Ravanini; S Calza; A Ravaggi; E Bandiera; F Facchetti; S Pecorelli; A D Santin
Journal:  Int J Gynecol Cancer       Date:  2008-02-19       Impact factor: 3.437

Review 8.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

9.  Disruption of occludin function in polarized epithelial cells activates the extrinsic pathway of apoptosis leading to cell extrusion without loss of transepithelial resistance.

Authors:  Neal E Beeman; Heidi K Baumgartner; Patricia G Webb; Jerome B Schaack; Margaret C Neville
Journal:  BMC Cell Biol       Date:  2009-12-09       Impact factor: 4.241

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  12 in total

Review 1.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

Review 2.  The Mammalian Blood-Testis Barrier: Its Biology and Regulation.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Endocr Rev       Date:  2015-09-10       Impact factor: 19.871

3.  Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors.

Authors:  Tomomi M Yamamoto; Patricia G Webb; Dana M Davis; Heidi K Baumgartner; Elizabeth R Woodruff; Saketh R Guntupalli; Margaret Neville; Kian Behbakht; Benjamin G Bitler
Journal:  Mol Cancer Ther       Date:  2022-04-01       Impact factor: 6.009

4.  Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel.

Authors:  Christopher Breed; Douglas A Hicks; Patricia G Webb; Carly E Galimanis; Benjamin G Bitler; Kian Behbakht; Heidi K Baumgartner
Journal:  Mol Cancer Res       Date:  2019-01-03       Impact factor: 5.852

5.  Occludin is required for apoptosis when claudin-claudin interactions are disrupted.

Authors:  N Beeman; P G Webb; H K Baumgartner
Journal:  Cell Death Dis       Date:  2012-02-23       Impact factor: 8.469

6.  Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.

Authors:  Douglas A Hicks; Carly E Galimanis; Patricia G Webb; Monique A Spillman; Kian Behbakht; Margaret C Neville; Heidi K Baumgartner
Journal:  BMC Cancer       Date:  2016-10-11       Impact factor: 4.430

7.  Developmental Expression of Claudins in the Mammary Gland.

Authors:  Heidi K Baumgartner; Michael C Rudolph; Palaniappian Ramanathan; Valerie Burns; Patricia Webb; Benjamin G Bitler; Torsten Stein; Ken Kobayashi; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-04-28       Impact factor: 2.673

8.  Increase in Toxicity of Anticancer Drugs by PMTPV, a Claudin-1-Binding Peptide, Mediated via Down-Regulation of Claudin-1 in Human Lung Adenocarcinoma A549 Cells.

Authors:  Haruka Nasako; Yui Takashina; Hiroaki Eguchi; Ayaka Ito; Yoshinobu Ishikawa; Toshiyuki Matsunaga; Satoshi Endo; Akira Ikari
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

9.  Claudins play a role in normal and tumor cell motility.

Authors:  Patricia G Webb; Monique A Spillman; Heidi K Baumgartner
Journal:  BMC Cell Biol       Date:  2013-03-23       Impact factor: 4.241

10.  Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions.

Authors:  Barbara Schlingmann; Christian E Overgaard; Samuel A Molina; K Sabrina Lynn; Leslie A Mitchell; StevenClaude Dorsainvil White; Alexa L Mattheyses; David M Guidot; Christopher T Capaldo; Michael Koval
Journal:  Nat Commun       Date:  2016-07-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.